SCHEMBL2305604

SCHEMBL2305604

N=C(CC(C(=O)OC(=O)CCC(=O)O)S(=O)(=O)O)OC(=O)CCC(=O)O

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM6B O15054 1/20 0.31
KDM5C P41229 1/20 0.31
EGLN1 Q9GZT9 1/20 0.31
PHF8 Q9UPP1 1/20 0.31
KDM2A Q9Y2K7 1/20 0.31
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1580299 0.89 TSHR (0.35) RECQL
SCHEMBL27831131 0.86 EGLN1 (0.34) KDM6BKDM5CEGLN1PHF8KDM2A
SCHEMBL28048877 0.85 RECQL (0.35) KDM6BKDM5CEGLN1PHF8KDM2A
SCHEMBL8347659 0.83 RECQL (0.34) RECQL
SCHEMBL1742070 0.81 RECQL (0.38) RECQL
SCHEMBL2053507 0.80 RECQL (0.42) RECQL
SCHEMBL22717361 0.79 DGKA (0.44) RECQL
SCHEMBL23355066 0.78 KDM2A (0.33) KDM6BKDM5CEGLN1PHF8KDM2A
SCHEMBL2726401 0.78 RECQL (0.30) RECQL
SCHEMBL9106478 0.73 PRKCA (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119816334-A Sealant for tissue closure 爱惜康股份有限公司 2025-04-11 CN claimed
WO-2023215453-A1 WATER ACTIVATED HYDROGEL-BASED MEDICAL PATCHES, FLEXIBLE SUBSTRATES AND METHODS OF MAKING AND USING SUCH PATCHES Pramand LLC (US) 2023-11-09 WO claimed
EP-4243820-A1 HYDROGELS FORMED IN SITU AND COMPOSITION DESIGN FOR INTRAUTERINE USE Pramand LLC (US) 2023-09-20 EP claimed
CN-116068167-A Separation and detection method of extracellular biomacromolecule 厦门福流生物科技有限公司 2023-05-05 CN claimed
WO-2022103944-A1 HYDROGELS FORMED IN SITU AND COMPOSITION DESIGN FOR INTRAUTERINE USE Pramand LLC (US) 2022-05-19 WO claimed
US-20220143276-A1 HYDROGELS FORMED IN SITU AND COMPOSITION DESIGN FOR INTRAUTERINE USE Pramand LLC 2022-05-12 US claimed
CN-1126441-A Amplification of vitamin B12 absorption System Using polymers BIOTECH AUSTRALIA PTY LTD (AU) 1996-07-10 CN claimed
US-12433485-B2 Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise DEXCOM, INC. (US) 2025-10-07 US disclosed
CN-120051307-A Flowable hydrogel gel composite sealant 爱惜康股份有限公司 2025-05-27 CN disclosed
CN-119816332-A Biodegradable lung sealant 爱惜康股份有限公司 2025-04-11 CN disclosed
CN-119816334-A Sealant for tissue closure 爱惜康股份有限公司 2025-04-11 CN disclosed
CN-119212740-A High elasticity medical sealant for flexible soft tissue 爱惜康股份有限公司 2024-12-27 CN disclosed
CN-117618628-A Biodegradable lung sealant 爱惜康股份有限公司 2024-03-01 CN disclosed
EP-1985699-A1 Controlled dissolution crosslinked protein crystals Altus Pharmaceuticals Inc. (US) 2008-10-29 EP disclosed
US-20030211127-A1 Controlled dissolution crosslinked prote in crystals ALTUS PHARMACEUTICALS INC. 2003-11-13 US disclosed
EP-1327680-A1 DEGRADED TPO AGONIST ANTIBODY CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-07-16 EP disclosed
US-20020137156-A1 CONTROLLED DISSOLUTION CROSSLINKED PROTEIN CRYSTALS ALTUS PHARMACEUTICALS INC. 2002-09-26 US disclosed
EP-0973878-A1 CONTROLLED DISSOLUTION CROSS-LINKED PROTEIN CRYSTALS Altus Biologics Inc. (US) 2000-01-26 EP disclosed
WO-1998046732-A1 CONTROLLED DISSOLUTION CROSS-LINKED PROTEIN CRYSTALS ALTUS BIOLOGICS INC. (US) 1998-10-22 WO disclosed
CN-1126441-A Amplification of vitamin B12 absorption System Using polymers BIOTECH AUSTRALIA PTY LTD (AU) 1996-07-10 CN disclosed